Outcome of the Japanese Immune Tolerance Induction (ITI) Registry and Predictors of Successful ITI

被引：0

作者：

Nogami, Keiji ^{[1
]}

Taki, Masashi ^{[2
]}

Matsushita, Tadashi ^{[3
]}

Ohga, Shouichi ^{[4
]}

Hanabusa, Hideji ^{[5
]}

Oka, Toshiaki ^{[6
]}

Horikoshi, Yasuo ^{[7
]}

Amano, Kagehiro ^{[8
]}

Shima, Midori ^{[1
]}

机构：

[1] Nara Med Univ, Dept Pediat, Kashihara, Nara 634, Japan

[2] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan

[3] Nagoya Univ Hosp, Dept Transfus Med, Nagoya, Aichi, Japan

[4] Yamaguchi Univ, Dept Pediat, Ube, Yamaguchi 755, Japan

[5] Ogikubo Hosp, Dept Hemalot, Tokyo, Japan

[6] Sapporo Tokushukai Hosp, Dept Pediat, Sapporo, Hokkaido, Japan

[7] Shizuoka Children Hosp, Dept Hematol Oncol, Shizuoka, Japan

[8] Tokyo Med Univ, Dept Lab Med, Tokyo 1608402, Japan

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] The North American Immune Tolerance Registry: Practices, outcomes, outcome predictors
DiMichele, DM
Kroner, BL
THROMBOSIS AND HAEMOSTASIS, 2002, 87 (01) : 52 - 57
[42] A retrospective study evaluating immune tolerance induction (ITI) with a plasma-derived factor VIII for patients with hemophilia A and high titer inhibitor
Escobar, M.
Sahffer, L.
Holguin, M.
McCavit, T.
Amega, N.
HAEMOPHILIA, 2019, 25 : 27 - 28
[43] International prospective randomised immune tolerance (ITI) study: interim analysis of therapeutic efficacy and safety
Hay, C. R. M.
Goldberg, I.
Foulkes, M.
Dimichele, D. M.
HAEMOPHILIA, 2010, 16 (02) : 405 - 405
[44] International prospective randomized immune tolerance (ITI) study: preliminary results of therapeutic efficacy and safety
Dimichele, D. M.
Goldberg, I.
Foulkes, M.
Hay, C. R. M.
HAEMOPHILIA, 2010, 16 : 29 - 29
[45] International prospective randomised immune tolerance (ITI) study: interim analysis of therapeutic efficacy and safety
Hay, C.
Goldberg, I.
Foulkes, M.
Dimichele, D.
HAEMOPHILIA, 2010, 16 : 73 - 73
[46] Prophylactic treatment and Rituximab subsequent immune tolerance induction therapy to improve inhibitor eradication on resistant ITI in severe hemophilia A patients with inhibitor
Chen, Yeu-Chin
Cheng, Shin-Nan
HAEMOPHILIA, 2016, 22 : 69 - 69
[47] IMMUNE TOLERANCE INDUCTION RESCUE (ITI-R) WITH HUMAN-CL RHFVIII IN HEMOPHILIA A PATIENTS AND HIGH-TITRE INHIBITORS
Zanon, E.
Pasca, S.
Pollio, B.
Ricca, I.
Marino, R.
HAEMATOLOGICA, 2019, 104 : 19 - 19
[48] Real-World Data of Immune Tolerance Induction Using rFVIIIFc in Subjects With Severe Hemophilia A With Inhibitors at High Risk for ITI Failure
Carcao, Manuel
Shapiro, Amy
Hwang, Nina
Pipe, Steven
Ahuja, Sanjay
Lieuw, Kenneth
Staber, Janice
Sun, Haowei Linda
Ding, Hilda
Wang, Michael
Steele, Macgregor
Tsao, Elisa
Feng, Jing
Al-Khateeb, Zahra
Dumont, Jennifer
Jain, Nisha
BLOOD, 2018, 132
[49] IMPACT OF FACTOR VIII GENE (F8) MUTATION ON IMMUNE TOLERANCE INDUCTION (ITI) OUTCOMES IN HAEMOPHILIA A PATIENTS WITH INHIBITORS IN THE OBSITI STUDY
Pavlova, A.
Escuriola-Ettingshausen, C.
Oldenburg, J.
HAEMOPHILIA, 2020, 26 : 54 - 54
[50] Induction of immune tolerance, the future of the registry
Ewing, NP
VOX SANGUINIS, 1996, 70 : 47 - 51

← 1 2 3 4 5 →